Noramco is a prominent specialty active pharmaceutical ingredient (API) development and manufacturing company. It focuses on advancing opioid and non-opioid products, playing a crucial role in addiction treatment and abuse prevention within the pharmaceuticals industry.
Specialties
Controlled substance manufacturing
Opioid and non-opioid development
DEA-compliant production security
High-purity active pharmaceutical ingredients
Formulation-friendly particle sizes
Products & Services
Opioid APIs
Non-Opioid APIs
Controlled Substance Manufacturing
Technical Support Services
Supply Chain Security
Contact Information
No contact information available
Competitors & Similar Companies(10)
Alkermes
Camber Pharmaceuticals
Mylan N.V.
Teva Pharmaceuticals
Sandoz
Sun Pharmaceutical Industries
Endo International plc
Purdue Pharma
Zogenix
Aytu BioPharma
News & Media
Search Terms:
noramco
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Noramco
Where is Noramco located?
The headquarter of Noramco is located in Wilmington, Delaware, United States
Noramco specializes in Controlled substance manufacturing, Opioid and non-opioid development, DEA-compliant production security, High-purity active pharmaceutical ingredients, Formulation-friendly particle sizes.
What products and services is Noramco likely to offer?
Competitors of Noramco are Alkermes, Camber Pharmaceuticals, Mylan N.V., Teva Pharmaceuticals, Sandoz, Sun Pharmaceutical Industries, Endo International plc, Purdue Pharma, Zogenix, Aytu BioPharma.
What does Noramco do?
Noramco is a prominent specialty active pharmaceutical ingredient (API) development and manufacturing company. It focuses on advancing opioid and non-opioid products, playing a crucial role in addiction treatment and abuse prevention within the pharmaceuticals industry.